# China NMPA Drug Inspection - Zhuhai Rundu Pharmaceutical Co Ltd - Ibuprofen sustained-release capsules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/zhuhai-rundu-pharmaceutical-co-ltd/2a347e23-7fcb-44d9-9f23-68e5b18bcfda/
Source feed: China

> China NMPA drug inspection for Zhuhai Rundu Pharmaceutical Co Ltd published June 17, 2021. Drug: Ibuprofen sustained-release capsules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Zhuhai Rundu Pharmaceutical Co Ltd
- Publication Date: 2021-06-17
- Drug Name: Ibuprofen sustained-release capsules
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/zhuhai-rundu-pharmaceutical-co-ltd/41358c8c-249a-4cdb-bb26-259ff492823f/